Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review

被引:85
作者
Farrington, C. [1 ]
机构
[1] Univ Cambridge, Inst Publ Hlth, Cambridge Ctr Hlth Serv Res CCHSR, Sch Clin Med, Cambridge, England
关键词
ARTIFICIAL PANCREAS; INSULIN DELIVERY; GLYCEMIC CONTROL; TYPE-1; ADULTS; TECHNOLOGY; ACCEPTANCE; WOMEN; PUMP; CARE;
D O I
10.1111/dme.13567
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a pressing need for new treatment regimens that enable improved glycaemic control and reduced diabetes self-management burdens. Closed-loop, or artificial pancreas, systems represent one of the most promising avenues in this regard. Closed-loop systems connect wearable continuous glucose monitor (CGM) sensors to smartphone- or tablet-mounted algorithms that process and model CGM data to deliver precise and frequently updated doses of fast-acting insulin (and glucagon in dual-hormone systems) to users via wearable pumps. Recent studies have demonstrated that closed-loop systems offer significant benefit in terms of improved glycaemic control. However, less attention has been paid to the psychosocial impact on users of closed-loop systems. This article reviews recent research on psychosocial aspects of closed-loop usage in light of preceding research on user experience of currently available technologies such as insulin pumps and CGM sensors. The small, but growing body of research in this field reports generally positive user experience and a number of experienced benefits including: reassurance and reduced anxiety, improved sleep and confidence, and time off' from diabetes demands. However, these benefits are counterbalanced by important challenges, ranging from variable levels of trust to concerns about physical bulk, technical glitches and difficulties incorporating closed-loop systems into everyday life. Future research should explore psychosocial aspects of closed-loop usage in more diverse groups and with regard to clinicians, as well as users, to ensure that the clinical benefits of closed-loop systems are realized at scale in routine medical care. What's new? Whereas most studies of closed-loop overlook psychosocial issues, there is growing recognition of the need to evaluate user experience of new diabetes technologies. This review evaluates research carried out on the psychosocial aspects of closed-loop system usage across paediatric, pregnant and adult populations, using qualitative and/or quantitative methodologies. Existing research identifies both benefits and burdens arising from the use of varied closed-loop systems. Future studies should be carried out with more consistent methodological rigour in addition to exploring psychosocial experiences in more diverse patient groups and in clinicians.
引用
收藏
页码:436 / 449
页数:14
相关论文
共 54 条
[1]   Closed-loop for type 1 diabetes - an introduction and appraisal for the generalist [J].
Bally, Lia ;
Thabit, Hood ;
Hovorka, Roman .
BMC MEDICINE, 2017, 15
[2]   Sensemaking in technology-use mediation: Adapting groupware technology in organizations [J].
Bansler J.P. ;
Havn E. .
Computer Supported Cooperative Work (CSCW), 2006, 15 (1) :55-91
[3]   Psychosocial aspects of closed-and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting [J].
Barnard, K. D. ;
Wysocki, T. ;
Thabit, H. ;
Evans, M. L. ;
Amiel, S. ;
Heller, S. ;
Young, A. ;
Hovorka, R. .
DIABETIC MEDICINE, 2015, 32 (05) :601-608
[4]  
Barnard Katharine D, 2017, J Diabetes Sci Technol, V11, P1080, DOI 10.1177/1932296817702656
[5]   Future Artificial Pancreas Technology for Type 1 Diabetes: What Do Users Want? [J].
Barnard, Katharine D. ;
Pinsker, Jordan E. ;
Oliver, Nick ;
Astle, Annabel ;
Dassau, Eyal ;
Kerr, David .
Diabetes Technology & Therapeutics, 2015, 17 (05) :311-315
[6]   Psychosocial Assessment of Artificial Pancreas (AP): Commentary and Review of Existing Measures and Their Applicability in AP Research [J].
Barnard, Katharine D. ;
Hood, Korey K. ;
Weissberg-Benchell, Jill ;
Aldred, Chris ;
Oliver, Nick ;
Laffel, Lori .
DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 (04) :295-300
[7]   Technological Advancement in the Treatment of Diabetes-Ignoring Psychosocial Impact at Our Peril [J].
Barnard, Katharine D. ;
Oliver, Nick .
DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 (03) :149-151
[8]   Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents [J].
Barnard, Katharine D. ;
Wysocki, Tim ;
Allen, Janet M. ;
Elleri, Daniela ;
Thabit, Hood ;
Leelarathna, Lalantha ;
Gulati, Arti ;
Nodale, Marianna ;
Dunger, David B. ;
Tinati, Tannaze ;
Hovorka, Roman .
BMJ OPEN DIABETES RESEARCH & CARE, 2014, 2 (01)
[9]   Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes [J].
Beato-Vibora, P. ;
Yeoh, E. ;
Rogers, H. ;
Hopkins, D. ;
Amiel, S. A. ;
Choudhary, P. .
DIABETIC MEDICINE, 2015, 32 (11) :1453-1459
[10]   Artificial Pancreas (AP) Clinical Trial Participants' Acceptance of Future AP Technology [J].
Bevier, Wendy C. ;
Fuller, Serena M. ;
Fuller, Ryan P. ;
Rubin, Richard R. ;
Dassau, Eyal ;
Doyle, Francis J., III ;
Jovanovic, Lois ;
Zisser, Howard C. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (09) :590-595